New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 19, 2013
10:11 EDTATML, CLF, HAL, HP, GILD, EFX, XLNX, TFM, PWER, PNM, O, MGM, LUFK, GNC, FET, CY, CRK, CRL, RVBDOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Atmel (ATML) upgraded to Buy from Hold at Needham... Best Buy (BBY) upgraded to Overweight from Equal Weight at Barclays... Charles River Labs (CRL) upgraded to Buy from Hold at Jefferies... Comstock Resources (CRK) upgraded to Outperform from Market Perform at BMO Capital... Cypress Semiconductor (CY) upgraded to Buy from Hold at Needham... Forum Energy (FET) upgraded to Outperform from Market Perform at FBR Capital... GNC Holdings (GNC) upgraded to Buy from Neutral at Goldman... Lufkin (LUFK) upgraded to Outperform from Market Perform at Wells Fargo... MGM Resorts (MGM) upgraded to Outperform from Sector Perform at RBC Capital... Realty Income (O) upgraded to Buy from Neutral at BofA/Merrill... PNM Resources (PNM) upgraded to Buy from Hold at Jefferies... Power-One (PWER) upgraded to Strong Buy from Outperform at Raymond James... The Fresh Market (TFM) upgraded to Buy from Neutral at Goldman... Xilinx (XLNX) upgraded to Buy from Neutral at BofA/Merrill... Equifax (EFX) upgraded to Overweight from Equal Weight at Evercore... Best Buy (BBY) upgraded to Buy from Hold at Stifel Nicolaus... Gilead (GILD) upgraded to Outperform from Neutral at Credit Suisse... Helmerich & Payne (HP) upgraded to Overweight from Equal Weight at Stephens... Halliburton (HAL) upgraded to Overweight from Equal Weight at Stephens... Cliffs Natural (CLF) upgraded to Overweight from Neutral at JPMorgan... Riverbed (RVBD) upgraded to Strong Buy from Buy at Needham.
News For ATML;CRL;CRK;CY;FET;GNC;LUFK;MGM;O;PNM;PWER;TFM;XLNX;EFX;GILD;HP;HAL;CLF;RVBD From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | all recent news | >>
October 9, 2014
09:43 EDTRVBDElliott 'commends' Riverbed board for initiating strategic review
Elliott Management Corporation commented on Riverbed Technology’s announcement of preliminary earnings and other actions: “We commend the Board for initiating a strategic review and believe that Riverbed is a great company with products customers value,” said Jesse Cohn, portfolio manager at Elliott Management. “We have made a $21 bid for the company, and our team and advisors look forward to completing our confirmatory diligence in an expedited fashion.”
08:39 EDTMGMMGM Resorts upgraded at Craig-Hallum
Subscribe for More Information
08:32 EDTRVBDRiverbed to undertake comprehensive review of stratetgic, financial alternatives
08:32 EDTRVBDRiverbed initiates restructuring plan to reduce annual costs by $20M-$25M
The company announced that it has initiated a restructuring plan in order to reduce annual costs by $20 million to $25 million and improve annual operating margins by 1% to 2%. The company expects these restructuring efforts to be substantially complete by the end of calendar 2014. “In light of current business conditions, we are taking decisive steps to improve our cost structure in order to drive enhanced operating performance,” said Jerry M. Kennelly, chairman and CEO, Riverbed. “We believe these actions enable us to deliver increased value to our shareholders while continuing to deliver the products and support expected by our customers.” In addition to these restructuring initiatives, Riverbed's Board of Directors has determined to undertake a comprehensive review, with the assistance of its advisors, of strategic and financial alternatives to enhance shareholder value. There is no set timetable for the review process. The company does not intend to disclose or comment on further developments unless and until its Board approves a specific action or it otherwise concludes its review of alternatives.
08:31 EDTRVBDRiverbed narrows Q3 adjusted EPS view to 30c-31c from 30c-32c
Consensus is 31c. Cuts Q3 revenue view to $276M-$277M from $285M-$291M, consensus $286.75M. The revised guidance primarily reflects lower than expected growth in the company’s WAN Optimization and virtual ADC businesses.
08:28 EDTGILDGilead to be challenged by AbbVie in HCV near-term, says Bernstein
Subscribe for More Information
07:43 EDTMGMMGM Resorts upgraded to Buy from Hold at Craig-Hallum
Subscribe for More Information
07:36 EDTHALHalliburton October volatility increases into Q3 and outlook
Subscribe for More Information
05:45 EDTHPHelmerich & Payne upgraded to Buy from Hold at Jefferies
Subscribe for More Information
October 8, 2014
18:31 EDTHALHalliburton awarded mature field contracts from Petroamazonas
Subscribe for More Information
16:26 EDTGILDOn The Fly: Closing Wrap
Subscribe for More Information
16:01 EDTCLF, GILDOptions Update; October 8, 2014
iPath S&P 500 VIX Short-Term Futures down 2.73 to 29.51. Option volume leaders: AAPL TSLA TWTR AMZN FB NFLX PBR AA CLF GILD according to Track Data.
15:49 EDTGILDAchillion, Gilead rise after late breaking abstract for AASLD posted
Shares of Achillion (ACHN) are higher after the company announced this morning that four abstracts have been accepted for presentation at The Liver Meeting, the annual meeting of the American Association for the Study of Liver Diseases. Among those four is a late breaker poster presentation providing updated results, including SVR12, from an ongoing Phase 2 proxy study evaluating Achillion's second-generation NS5A inhibitor, in combination with sofosbuvir, without ribavirin, for eight weeks of treatment in patients with treatment-naïve genotype 1 chronic hepatitis C virus infection. Sofosbuvir is sold under the brand name Sovaldi by Gilead Sciences (GILD). In a note to investors, FBR Capital noted that the "surprise" late-breaking poster for the meeting showed a 100% cure rate for the combination therapy. In late afternoon trading, Achillion shares are up 10% to $10.74 while Gilead is up 4.3% to $108.78.
14:53 EDTCLFCliffs Natural CEO says hasn't sold shares, no clock on non-core sales, WSJ says
Subscribe for More Information
13:41 EDTTFMThe Fresh Market backs FY14 adjusted EPS view $1.56-$1.66, consensus $1.57
Subscribe for More Information
10:38 EDTCYHigh option volume stocks
High option volume stocks: FRAN RMTI ACM CY CLNY SMH BEAV SIG CTB DUG SHLD
09:38 EDTCLFActive equity options trading on open
Subscribe for More Information
08:38 EDTCYCypress Semiconductor 2015 results could beat expectations, says Sterne Agee
Subscribe for More Information
07:18 EDTGILDInfectious Diseases Society of America to hold a conference
ID Week 2014 is being held in Philadelphia on October 8-12.
06:01 EDTCLFCliffs Natural implied volatility of 99 at upper end of index mean range
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | 6 | 7 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use